PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF

This study highlights immune-metabolism disorder triggered by HBV exacerbation as a potential mechanism of HBV-ACLF and may indicate a novel diagnostic and treatment target to reduce HBV-ACLF-related mortality.